Our mission is to provide innovative vision products that enhance quality of life by helping people see better. From vision research to eye health, learn more at Alcon.com.

Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care.

Alcon provides Eye Care Professionals comprehensive eye health education, hands-on experiential learning opportunities and cutting-edge virtual reality technology for immersive training experiences at our state-of-the-art facilities around the world.

Alcon offers professional development opportunities and experience as a global leader in eye care. Search Alcon pharmaceutical jobs, internships and more at Alcon.com.

3 天之前 · Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives.

Contact Alcon with any product quality concerns or to report a question. Alcon welcomes your feedback to continue driving us as the global leader in eye care.

At the beginning of 2022, Alcon reaffirmed our commitment in glaucoma with our acquisition of Ivantis, Inc. Our goal was simple: to introduce Hydrus ® Microstent, a minimally invasive glaucoma surgery (MIGS) device, proven to lower intraocular pressure in patients with mild to moderate primary open angle glaucoma in conjunction with cataract ...

Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation

Alcon aspires to improve lives, strengthen communities and create long-term value by innovating products that improve sight. Our strategy leads with our commitment to enable communities to access critical eye care services so that everyone can See Brilliantly.

2024年5月13日 · Alcon reported diluted earnings per share of $0.50 and core diluted earnings per share 2 of $0.78 in the first quarter of 2024. "Our first-quarter results reflect the outstanding work done by our more than 25,000 associates across both our Surgical and Vision Care franchises," said David J. Endicott, Alcon's Chief Executive Officer.